Revolution Medicines Inc (RVMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -405,524 | -249,236 | -116,003 | -436,367 | -274,830 |
| Depreciation Amortization | -27,302 | -20,586 | -12,481 | -12,896 | -7,121 |
| Income taxes - deferred | N/A | N/A | N/A | -3,910 | -3,867 |
| Accounts receivable | 1,254 | 1,254 | 1,254 | 3,419 | 4,364 |
| Accounts payable and accrued liabilities | -35,828 | -33,040 | -28,960 | 32,469 | 8,164 |
| Other Working Capital | -41,614 | -51,953 | -47,213 | 40,662 | 19,463 |
| Other Operating Activity | 89,868 | 64,834 | 42,843 | 26,051 | 23,818 |
| Operating Cash Flow | $-419,146 | $-288,727 | $-160,560 | $-350,572 | $-230,009 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -152,405 | -134,456 | -244,799 | -334,869 | 43,216 |
| PPE Investments | -9,086 | -5,566 | -3,167 | -7,729 | -5,412 |
| Investing Cash Flow | $-161,491 | $-140,022 | $-247,966 | $-342,598 | $37,804 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 85,608 | 8,314 | 810 | 1,233,226 | 389,846 |
| Other Financing Activity | 0 | 0 | 0 | -4,026 | 0 |
| Financing Cash Flow | $85,608 | $8,314 | $810 | $1,229,200 | $389,846 |
| Beginning Cash Position | 699,179 | 699,179 | 699,179 | 163,149 | 163,149 |
| End Cash Position | 204,150 | 278,744 | 291,463 | 699,179 | 360,790 |
| Net Cash Flow | $-495,029 | $-420,435 | $-407,716 | $536,030 | $197,641 |
| Free Cash Flow | |||||
| Operating Cash Flow | -419,146 | -288,727 | -160,560 | -350,572 | -230,009 |
| Capital Expenditure | -9,086 | -5,566 | -3,167 | -7,729 | -5,412 |
| Free Cash Flow | -428,232 | -294,293 | -163,727 | -358,301 | -235,421 |